Background:
INTRODUCTION
Pyrazole-5-one derivatives possess various types of biological activities. It is due to their wide use in medicinal chemistry some of them possess anti-tuberculosis, anti-neoplastic, anti-diabetic, anti-fertility, anti-thyroid and anti microbial activity [1 -4] . growth regulators. Some Organophosphorus compounds have been described in the literature as inhibitors of bacterial [5] , herbicides, insecticides, pesticides [6, 7] , anti-fungal agents [8] , anti-HIV [9] , anti-cancer [10] , anti-viral and antiinflammatory [11] .
A good deal of importance was given to Phosphonate derivatives in the field of organophosphorus heterocyclic chemistry due to their unique biological applications [12] . In view of the above observations, we synthesized Mannich bases containing Pyrazole-5-one Phosphonates and screening for possible biological and pharmacological activities.
RESULTS AND DISCUSSION

Chemistry
All the chemicals used in the present investigation were purchased from Sigma-Aldrich Chemicals company, Inc. USA. And used without further purification. TLC was performed on aluminium sheet of silica gel 60F254, E-Merk, Germany using iodine as visualizing agent. Melting points were determined in open capillary tubes on Mel-Temp apparatus and are uncorrected. Column chromatography was performed on silica gel with different solvent systems as eluents to afford the pure compound. The IR Spectra were recorded as KBr pellets on Perkin-Elmer 1000 units, instruments. All 1 H and 13 C-NMR spectra were recorded on a Varian XL-300 spectrometer operating at 400MHz for 1 H -NMR and 75 MHz for 13 C-NMR. 31 P-NMR spectra were recorded on a Varian XL-spectrometer operating at 161.89MHz. The compounds were dissolved in DMSO-d 6 and Chemical shifts were referenced to TMS ( 1 H and 13 C-NMR) and 85% H 3 PO 4 ( 31 P-NMR). Mass spectral data was recorded on FAB-MS instrument at 70ev with direct inlet system. Elemental analysis was recorded on a Carlo Erba 1108 elemental Analyzer, Central Drug Research Institute, Lucknow, India.
CONCLUSION
The newly synthesized compounds Diethyl ((4-fluorophenyl)/(4-chlorophenyl)/(4-bromophenyl)/(4-(trifluoromethyl) phenyl) amino) (3-methyl-1-(morpholino methyl)/(4-methylpiperazin-1-yl) -5-oxo-4, 5-dihydro-1H-pyrazol-4-yl) methyl) phosphonates 6(a-h) were found to be active in the study of antifungal activity. It can be concluded that this class of compounds certainly holds great promise towards the pursuit to discover novel classes of antimicrobial agents.
EXPERIMENTAL SECTION
General Procedure A for Preparation of 3(a-d)
The quantity of 4-fluoro aniline (2.2gr, 0.020 mole) (2a) and 3 -Methyl -5 -oxo -4, 5 -dihydro -1H -pyrazole -4 -carbaldehyde (1.746gr, 0.014mole) (1) were dissolved in absolute alcohol, to this three drops of acetic acid is added then heated on a steam bath for 5-6 hours at 100°C. After standing for 24 hours at room temperature, the crude product was purified by column chromatography (60-120 mesh silica gel,eluent: 10% EtoAc pet ether). Finally, the product compound 4 -(((4 -fluorophenyl) imino) methyl) -3 -methyl -1H -pyrazol -5(4H) -one (3a) which was recrystallized from warm absolute alcohol. Yield 75%, m p 153-155°C.
The similar procedure was adopted to synthesize 3(b-d) (2.7gr, 0.011mol -3b, 3.1gr, 0.011mol-3c, 2.9gr, 0.018mol-3d) by condensing 3-Methyl-5-oxo-4, 5-dihydro-1H-pyrazole-4-carbaldehyde (1) with 4-chloro aniline (2.5gr, 0.020 mol-2b), 4-bromo aniline (3.44gr, 0.20mol-2c) and 4-trifluoro aniline (3.22gr, 0.020mol-2d) respectively.
General Procedure B for Preparation of 5(a-h)
A mixture of 4-(((4-fluorophenyl) imino) methyl)-3-methyl-1H-pyrazol-5(4H)-one(0.87gr, 0.004mol) (3a), morpholine (0.78gr, 0.09mol) (4a) (0.15 mol) and water 20 ml was stirred to obtained a clear solution. To this solution, HCHO (0.05 mol) and DMF were added in ice cold condition and stirred for 2 hours in an ice bath and left over night at room temperature. The progress of the reaction was monitored by TLC using cyclohexane and ethylacetate (7:3) solvent mixture as a mobile phase. At the end of the reaction, the mixture was taken in a 30 ml dichloromethane and neutralized with 50 ml 1N NaOH solution, after neutralization the mixture was extracted with CH 2 Cl 2 (3(25 ml). The combined extract was dried on Na 2 SO 4 . After filtration, the solvent was removed with rota evaporator. The residue was purified by column chromatography, using 60-120 mesh silica and CHCl 3 solvent was used as an elutent. Finally the product compound 4 -(((4 -fluorophenyl) imino) methyl) -3 -methyl -1 -(morpholinomethyl) -1H -pyrazol -5(4H) -one(0.891gr, 0.0028mol) (5a) was purified from aqueous dimethyl formamide. Yield 70%, m p 162-164°C.
The similar procedure was adopted to synthesize 5(b-h) (1.305gr, 0.003mol-5b, 1.32gr, 0.0035mol-5c, 1.28gr,0.0035mol-5d, 1,15gr, 0.0035mol-5e, 1.13gr, 0.0032mol-5f, 1.27gr, 0.0032mol-5g, 1.23gr, 0.0032mol-5h) by condensing 3(a-d) (0.87gr, 0.004mol-3a, 1.414gr, 0.006mol-3b, 1.40gr, 0.005mol-3c, 1.34gr, 0.005mol-3d) with morpholine (0.78gr, 0.009mol) (4a) N-methylpiperazine (0.90gr, 0.005mol) (4b) respectively.
General Procedure C for Preparation of 6(a-h) (Scheme-1)
A mixture of 4-(((4-fluorophenyl) imino) methyl)-3-methyl-1-(morpholinomethyl)-1H-pyrazol-5(4H)-one(0.95gr, 0.003mol) (5a) and Diethyl phosphite (1.24 ml, 0.009 mol) in anhydrous toluene (15ml) was added dropwise. Stirring was continued at room temperature for another 0.5 hour, after which the mixture was heated under reflux for 4-6 hours. The reaction was monitored by TLC on silica gel using petroleum ether-ethyl acetate (1:2 v/v). After completion of the reaction, the solvent was removed by rota evaporator and the resulting residue was purified by column chromatography on silicagel (100-200 mesh) and ethyl acetae-hexane, (3:7 ratio) as an eluent to afford pure Diethyl (((4-fluorophenyl) amino) (3-methyl -1-(morpholinomethyl) -5-oxo -4,5-dihydro-1H-pyrazol-4-yl) methyl) phosphonates(0.95gr, 0.002mol) (6a), was purified from aqueous dimethyl formamide. Yield 70%, m p 176-178°C.
The similar procedure was adopted to synthesize 6(b-h) (0.96gr, 0.002mol-6b, 1.03gr, 0.002mol-6c, 0.98gr, 0.001mol-6d, 0.98gr, 0.002mol-6e, 1.00gr, 0.002mol-6f, 1.00gr, 0.001mol-6g, 1.16gr, 0.002mol-6h) by the reaction between 5(b-h) with Diethyl phosphite. The structure of these newly synthesized compounds of 6(a-h) were established by IR, 1 H-NMR, 13 C-NMR, 31 P-NMR, and mass data and elemental analysis. 
Diethyl (((4 -chorophenyl) amino) (3 -methyl -1 -(morpholinomethyl) -5-oxo-4, 5 -dihydro-1H-pyrazol-4-yl) methyl) phosphonates (6b)
according
Biological Activity
The antimicrobial activity [13] of these newly synthesized compounds was performed according to disc diffusion method, as recommended by the National Committee for Clinical Laboratory. The synthesized compounds were used at the concentration of 250μg/ml DMF as a solvent [14] .
Anti-Bacterial Activity
The antibacterial activity of Mannich bases containing Pyrazole-5-one Phosphonates 6(a-h) were screened against the Staphylococcus aureus and Bacillus cerus (gram positive) and Escherichia coli, Pseudomonasaeruginosa (gram negative) organisms. Most of the compounds exhibit good antibacterial activity against both bacteria. The presence of fluoro (6d, 6h) and chloro (6b, 6f) were showed more activity than other substituted compounds. Here Amoxicillin is tested as reference compound to compare the activity. The anti-bacterial activity was shown in the 
Anti-Fungal Activity
The anti-fungal activity of Mannich bases containing Pyrazole-5-one Phosphonates 6(a-h) was screened against the Aspergillus niger and Candida albicans. Most of the compounds exhibit good antifungal activity against both fungai. The presence of fluoro (6d, 6h) and chloro (6b, 6f) were showed more activity than other substituted compounds. Here Ketoconazole is tested as reference compound to compare the activity. The anti-fungal activity was shown in the 
